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Abstract
Background: Mucuna pruriens, Tribulus terrestris and Ashwagandha (Withania somnifera) are widely known as
antioxidant effective herbals and have been reported to possess aphrodisiac activities in traditional usages. In this
study, we determined the effects of these herbals on sexual functions, serum biochemical parameters, oxidative
stress and levels of NF-κB, Nrf2, and HO-1 in reproductive tissues.
Methods: Thirty-five male rats were divided into five groups: the control group, sildenafil-treated group (5 mg/kg/d),
Mucuna, Tribulus and Ashwagandha groups. The extract groups were treated orally either with Mucuna, Tribulus or
Ashwagandha (300 mg/kg b.w.) for 8 weeks.
Results: All of the extracts were found to be significantly effective in sexual functioning and antioxidant capacity and
Tribulus showed the highest effectiveness. Serum testosterone levels significantly increased in Tribulus and
Ashwagandha groups in comparison to control group. Tribulus was able to reduce the levels of NF-κB and increase the
levels of Nrf2 and HO-1 to a much greater extent than Mucuna and Ashwagandha.
Conclusions: These results demonstrate for the first time that Mucuna, Tribulus and Ashwagandha supplementation
improves sexual function in male rats via activating Nrf2/ HO-1 pathway while inhibiting the NF-κB levels. Moreover,
Tribulus terrestris extract was found to be more bioavailable from Ashwagandha extract followed by Mucuna extract.
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Abbreviations: ALP, Alkaline phosphatase; ALT, Alanine aminotransferase; ARE, Antioxidant response element;
AST, Aspartate aminotransferase; CK, Creatine kinase; FSH, Follicle-stimulating hormone; GRAN, Granulocyte;
HCT, Hematocrit; HGB, Hemoglobin; HO-1, Heme oxygenase-1; LH, Luteinizing hormone; LWBC, Leukocyte white
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Background
Male infertility and reproductive dysfunctions are ser-
ious widespread health problems and almost half of the
human infertility is considered to be male, moreover, the
etiology is not obvious in 40 to 50 % of infertile males as
well [1, 2]. It has also been observed that oligospermia is
the single most common reason for the depressed male
fertility [3]. Metabolic generation of reactive oxygen spe-
cies (ROS) is required for male sexual function, whilst
high levels of ROS may be the reason for low sperm
quality and male infertility [4].
Animal experiments suggest that a better treatment for
sexual dysfunction or infertility may not only improve sex-
ual relationships but also the overall quality of life [5]. Free
radicals are extremely reactive molecules which include re-
active oxygen species (ROS) and also nitrogen species.
These radicals are normally generated by subcellular com-
partments of testes, particularly mitochondria; however ex-
cessive free radical production can cause tissue injury and
cell death and result as depleting the antioxidant status [6].
In many countries, different varieties of plants have been
used as sexual stimulants in traditional medicine including
Mucuna pruriens, Tribulus terrestris, and Ashwagandha
[7–9]. Mucuna pruriens (commonly known as Cowitch), a
leguminous plant grown in Africa, South America, and
South Asia is identified as an herbal medicine for improv-
ing the antioxidant, antidiabetic, antidiabetes-induced
erectile dysfunction, anti-inflammatory, neuroprotective,
aphrodisiac, anticataleptic and antiepileptic, antibacterial,
cardioprotective properties [10–13]. Tribulus terrestris (be-
longing to family Zygophyllaceae), known as Gokshur or
Gokharu, has been used for a long time for treatment of
various kinds of diseases by anti-inflammatory, antidia-
betic, hypolipidemic, cardiotonic, hepatoprotective, anal-
gesic, antispasmodic, anticancer, and antibacterial activities
[14, 15]. Withania somnifera (Ashwagandha) is one of the
most valuable herbs in the traditional Indian systems of
medicine [16] and it possesses immunomodulatory, anti-
cancer, antimetastatic, antistress, antioxidant, hemopoietic,
rejuvenating properties and besides its positive influence
on the endocrine, cardiopulmonary and central nervous
system [17, 18]. Additionally, Mucuna pruriens also is
shown to improve sperm density, motility, serum tes-
tosterone levels, male sexual behavior and even andro-
genic in hyperglycemic male rats [19, 20]. Tribulus
terrestris has the potential to increase hormone levels
of testosterone and enhance premature ejaculation [21,
22]. Ashwagandha has the capacity to improve blood
circulation in the body, thus naturally enhance sperm
quality [8, 23].
Diminishing the excessive ROS levels is suggested for
being a penetrating way to overcome infertility problems
during the aging [24] and even enhancing the testoster-
one alone were shown to reduce ROS production and
increase p-eNOS/eNOS ratio in the castrated rats, there-
fore, ameliorate erectile dysfunction as well [25]. The
signaling pathway of erythroid 2-related factor 2 (Nrf2)
antioxidant response element (ARE) plays a key role in
oxidative stress response and Nrf2 was suggested to be a
transcription factor that promotes the expression of
many crucial antioxidant genes [26, 27]. Heme oxygen-
ase (HO) pathway has a major role in male reproductive
system and sexual dysfunctions and heat shock protein
32 or heme oxygenase-1 protein (HO-1) is known to be
an inducible isoform protein and it is induced by many
different conditions and agents including hypoxia, cyto-
kines, oxidative stress, heat shock, and reactive oxygen
species [28, 29]. The nuclear factor kappa-B (NF-κB), is
an enhancer-binding transcription factor located in the
immune response and participates to cell proliferation
and apoptosis, meanwhile, NF-κB binds to DNA at
50 kDa subunit (p50) and involves the transcriptional ac-
tivation with the 65 kDa subunit (p65) [30]. The molecu-
lar mechanism including NF-κB and Nrf2 pathway of
Tribulus terrestris, Mucuna pruriens and Ashwagandha
extracts as an antioxidant in reproductive tissues of male
rats has not been investigated. Based on the current
knowledge, the aim of the present study was to deter-
mine the effects of the Tribulus terrestris, Mucuna prur-
iens and Ashwagandha on levels of serum biochemical
parameters, hormones, MDA (malondialdehyde) and the




Thirty-five Sprague-Dawley male rats (age: 8 weeks,
weight: 180 ± 20 g) were provided by the Laboratory of
Experimental Animals of Inonu University, Malatya,
Turkey and the Animal Care Committee of the Inonu
University approved this study (2014/A-53). The rats
were housed in standard plastic cages (10.25″w ×
18.75″1 × 4″d), in a controlled environment with hu-
midity (55 ± 5 %) under a 12:12-h light-dark cycle at 22 °
C. Rats were provided with standard diet and tap water
ad libitum. The animals were housed in plastic wire me-
shed cages in the animal house. The wooden material
used as bedding was replaced every 3 days. All the ex-
periments were conducted between 09.30 and 17.00 h to
minimize the effects of environmental changes.
Experimental design
The rats were housed in plastic metabolic cages and
were randomly divided into 5 groups of seven. These
groups were as follows: (i) Group I – Negative control:
Rats only fed with standard diet and tap water as vehicle,
(ii) Group II – Positive control: Rats were fed with
standard diet and treated with sildenafil citrate (Viagra,
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Pfizer) orally via an intragastric tube (5 mg/kg/d), (iii)
Group III: Rats were fed with standard diet and treated
with Mucuna pruriens (iv) Group IV: Rats were fed with
standard diet treated with Tribulus terrestris Group V:
Rats were fed with standard diet and treated with
Ashwagandha.
The animals were treated with dried seed powder of
Mucuna pruriens extracted with an ethanol-water mix-
ture (70:30) (Item code: 51002; active ingredient:
min.20 % L-DOPA), dried fruit extract powder of Tribu-
lus terrestris extracted with a methanol-water mixture
(70:30) (Item code: 35002; active ingredient: min. 40 %
saponis) and dried roots of the plant Withania somnifera
extracted with a methanol-water mixture (70:30) (Item
code: 13002; active ingredients: min: 2.5 % total withano-
loids). The purity of all the extracts was 98 %. All the ex-
tracts were dissolved in distilled water and administered
orally via an intragastric tube daily with an optimal dose
of 300 mg/kg body weight for 8 weeks in parallel with
sildenafil citrate treated positive control group which
was also administered in the same way like the other ex-
tract treated groups based on preliminary and published
data [31]. All of the herbal extracts were supplied by
Omni Active Health Technologies Pvt. Ltd. (Mumbai,
India).
Animals were sacrificed under the ether anesthesia
and the testes, epididymis, vas deferens, and ventral
prostate were removed and cleared from adhering con-
nective tissue and weighed. One of the testis samples
was fixed in Bouin’s solution for histopathological exam-
ination. The other testes samples were stored at 20 ° C
for biochemical analyses. Testes were taken from 20 °C
freezer and immediately transferred to the cold glass
tubes. Then, the testes were diluted with a nine-fold vol-
ume of phosphate-buffered saline (PBS; pH 7.4). For the
enzymatic analyses, testes were minced in a glass and
homogenized by a Teflon–glass homogenizer for 3 min
in cold physiological saline on ice [32]. The cauda epidi-
dymidis was cut longitudinally with a pair of fine-
pointed scissors and compressed with forceps. The
sperm was released by mincing the cauda epididymis
into pieces on the Petri dishes that contained phosphate
buffer saline (PBS) for sperm characteristics analysis.
Since epididymis came in pairs, one cauda epididymis
was put in a Petri dish containing 10 ml of 0.1 M PBS
specifically for sperm count and sperm motility analysis
while the other cauda epididymis put in another Petri
dish containing 1 ml 0.1 M PBS for sperm viability and
sperm morphology. The spermatozoa were allowed to
flow out from cauda epididymis into the buffer. Then,
the sperm suspensions were left at room temperature
for 10 min for the suspension to allow sperm to swim
out of the lumen of the cauda epididymidis for sperm
characteristics analysis.
Sperm quality
Sperm analyses were performed using the methods pre-
viously reported in the study by Turk et al. [33]. Sperm
count was determined using the hemocytometer under a
light microscope. A cover slip was placed on the
hemocytometer before a drop with 10 μl of caudal epi-
didymal sperm solution loaded under the cover slip.
Haemocytometer was again used for sperm motility ana-
lysis. A cover slip was placed on the hemocytometer be-
fore a drop with 10 μL of caudal epididymal sperm
solution was loaded under the cover slip. Sperm viability
analysis will be used the sperm from the other cauda
epididymis that will be put in a Petri dish with 1 ml
0.1 M PBS. On a clean glass slide, 1 drop of sperm sus-
pension will be gently mixed with 3 drops of eosin using
the sharp glass slide end. After 30 s, 1 drop of nigrosin
was mixed together with the solution and a smear will
be made. The smear will be then air-dried and observed
under x200 magnification of imaging microscope. The
sperm will be counted based on the degree of membrane
permeability. The dead sperm will be showed pink color-
ation of the head whereas the viable sperm will be
showed whitish or colorless head. Sperm morphology
analysis will be used the same sperm smear made for
sperm viability analysis. This time, the sperm will be ob-
served under x400 magnification of imaging microscope
to clearly evaluate the morphology of the sperm head,
neck, and tail. The sperm will be generally classified as
normal or abnormal without further characterized the
types of abnormality found on the sperm. The normal
sperm will be given a score of 100 and the abnormal one
will be given a score of “0” to enable statistical analysis
by using Statistical Analysis System (SAS) to be carried
out easily.
Laboratory analyses
Hematology parameters in whole blood samples were
analyzed by automated analyzer Exigo EOS Vet (Boule
Medical AB, Spanga, Sweden). Serum aspartate amino-
transferase (AST), alanine aminotransferase (ALT), and
alkaline phosphatase (ALP), creatine kinase (CK) con-
centrations were analyzed by the biochemical analyzer
(Samsung LABGEO-PT10). Serum testosterone, luteinizing
hormone (LH), follicle stimulating hormone (FSH) levels
were measured by using an ELISA kit (Cayman Chemical
Company, Ann Arbor, Michigan, USA; Elx-800; Bio-Tek
Instruments Inc, Vermont, USA).
A 10 % (w/v) tissue homogenate was prepared in
10 mM phosphate buffer (pH 7.4). The homogenate was
centrifuged at 13,000 g for 10 min at 4 °C. The super-
natant was collected and stored at -80 °C. The concen-
tration of MDA, an index of lipid peroxidation and
oxidative stress, was measured using the fully automatic
HPLC (Shimadzu, Kyoto, Japan) equipped with a pump
Sahin et al. BMC Complementary and Alternative Medicine  (2016) 16:318 Page 3 of 11
(LC-20 AD), an ultraviolet-visible detector (SPD-20A),
an inertsil ODS-3 C18 column (250 × 4.6 mm, 5 m), a
column oven (CTO-10ASVP), an autosampler (SIL-
20A), a degasser unit (DGU-20A5) and a computer sys-
tem with LC solution Software (Shimadzu) [34].
Western blot analysis for NF-κB p65, Nrf-2 and HO-1
Protein (NF-κB, Nrf2, and HO-1) levels were analyzed
by western blotting technique. For western blotting; epi-
didymis, prostate, testes and vas deferens tissues of the
rats were removed after sacrification to analyze the tar-
get protein expressions among the groups. Briefly, accur-
ately weighed each tissue sample was homogenized in
1:10 (w/v) in 10 mM Tris-HCl buffer at pH 7.4, contain-
ing 0.1 mM NaCl, 0.1 mM phenylmethylsulfonyl fluor-
ide, and 5 μM soybean (soluble powder; Sigma, St.
Louis, MO, USA) as trypsin inhibitor. Tissue homogen-
ate was centrifuged at 15,000 g at 4 °C for 30 min, and
the supernatant was transferred into fresh tubes. Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis sam-
ple buffer containing 2 % β-mercaptoethanol was added
to the supernatant. Equal amounts of protein (20 μg)
were electrophoresed and subsequently transferred to
nitrocellulose membrane (Schleicher and Schuell Inc.,
Keene, NH, USA). Nitrocellulose blots were washed
twice for 5 min in phosphate buffered saline (PBS) and
blocked with 1 % bovine serum albumin in PBS for 1 h
prior to the application of primary antibody. Rat anti-
bodies against NF-κB 65, Nrf-2 and HO-1 were pur-
chased from Abcam (Cambridge, UK). Primary antibody
was diluted (1:1000) in the same buffer containing
0.05 % Tween-20. The nitrocellulose membrane was in-
cubated overnight at 4 °C with protein antibody. The
blots were washed and incubated with horseradish
peroxidase-conjugated goat anti-mouse IgG (Abcam,
Cambridge, UK). Specific binding was detected using di-
aminobenzidine and hydrogen peroxide as substrates.
Protein loading was controlled using a monoclonal
mouse antibody against β-actin antibody (A5316; Sigma).
Band intensities of the proteins were quantified by
densitometric analysis using an image analysis system
(Image J; National Institute of Health, Bethesda, USA).
Samples were analyzed in quadruplicate, and a represen-
tative blot is shown in the respective figures. Results
were normalized to the β-actin expression in each group
as percent of control.
Statistical analysis
Data analysis was performed using Statistical Analysis
System (SAS) version 9.2. Data of body weight, serum
testosterone, mounting latency and mounting frequency
were subjected to analysis of variance (ANOVA) to
analyze the significant treatment effect and the mean be-
tween the groups was compared using Duncan Multiple
Range Test if F value was significant at P < 0.05.
Results
No significant change of the extracts was observed on
final body weight, absolute and relative reproductive
organ weights of the animals among the groups (P >
0.05) (Table 1). Sexual behavior changes were presented
in Table 2. All the treatment groups showed significant
Table 1 The effects of extracts on final body weight, absolute and relative reproductive organ weights
Item Groups –P–
Control Sildenafil Mucuna pruriens Tribulus terrestris Ashwagandha
Final body weight, g 324.00 ± 24.84 316.57 ± 17.99 312.00 ± 29.73 307.71 ± 52.45 331.80 ± 28.31 >0.05
Testis, g 1.39 ± 0.07 1.35 ± 0.11 1.35 ± 0.09 1.36 ± 0.14 1.33 ± 0.08 >0.05
Whole epididymis, g 0.58 ± 0.05 0.61 ± 0.04 0.56 ± 0.05 0.58 ± 0.07 0.59 ± 0.04 >0.05
Right cauda epididymis, g 0.25 ± 0.03 0.24 ± 0.03 0.24 ± 0.03 0.23 ± 0.05 0.23 ± 0.02 >0.05
Vas deferens, g 0.12 ± 0.01 0.13 ± 0.01 0.12 ± 0.01 0.13 ± 0.01 0.13 ± 0.01 >0.05
Seminal vesicles, g 1.16 ± 0.30 1.10 ± 0.25 1.09 ± 0.18 1.17 ± 0.24 1.39 ± 0.31 >0.05
Ventral prostate, g 0.43 ± 0.07 0.49 ± 0.07 0.41 ± 0.07 0.50 ± 0.17 0.48 ± 0.18 >0.05
Testis*, % 0.43 ± 0.04 0.43 ± 0.04 0.43 ± 0.05 0.45 ± 0.05 0.40 ± 0.03 >0.05
Whole epididymis*, % 0.18 ± 0.02 0.19 ± 0.02 0.18 ± 0.02 0.19 ± 0.02 0.18 ± 0.01 >0.05
Right cauda epididymis*, % 0.08 ± 0.01 0.08 ± 0.01 0.08 ± 0.01 0.08 ± 0.01 0.07 ± 0.004 >0.05
Vas deferens*, % 0.04 ± 0.005 0.04 ± 0.008 0.04 ± 0.003 0.04 ± 0.007 0.04 ± 0.004 >0.05
Seminal vesicles*, % 0.36 ± 0.09 0.35 ± 0.09 0.35 ± 0.05 0.38 ± 0.06 0.42 ± 0.9 >0.05
Ventral prostate*, % 0.13 ± 0.02 0.15 ± 0.02 0.13 ± 0.02 0.16 ± 0.04 0.14 ± 0.05 >0.05
*Relative reproductive organ weights [organ weight (g) / final body weight (g) X 100]
Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with
Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the
same row (a–c) indicate group mean differences (p < 0.05)
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decreases in mounting latency and intromission latency
values (P < 0.0001), and significant increases in mounting
frequency and intromission frequency values when com-
pared to the standard control group (P < 0.0001).
The effects of extracts on sperm motility, sperm count,
and abnormal sperm rate were shown in Table 3. Sperm
motility was significantly different between the treatment
groups (P < 0.05). Rats that were supplemented with Mu-
cuna and Tribulus showed higher mean value for sperm
motility compared with the control groups as shown in
Table 3. However, Tribulus group showed the highest
total sperm motility percentage than the other groups
with a considerably high mean level of 84.29 % (P <
0.05). Mucuna, Tribulus, and Ashwagandha supplemen-
tation also produced a significant increase in sperm
counts compared to the control group (P < 0.05). Tribu-
lus group indicated the highest number of sperm count
with a mean level of 161.42 million/right cauda epididy-
mis (P < 0.05). However, there was no statistically signifi-
cant difference in head, tail and total abnormal sperm
rates (P > 0.05).
The hematological data of the groups was presented in
Table 4. No statistical significance was detected among
all blood parameters of the Ashwagandha, Tribulus and
Mucuna plant extract groups when compared to positive
control sildenafil group and negative control standard
group (P > 0.05). The effects of the extracts on serum
biochemical parameters were shown in Table 5. There
was no significant difference among the AST, ALT, CK,
urea and creatine levels between the groups (P > 0.05),
despite serum ALP level of Mucuna group was lower
than the other groups (P < 0.05).
When we examined the effects of extracts on serum
hormones and MDA (Table 6), FSH and LH hormone
levels showed no significance (P > 0.05) but serum tes-
tosterone levels were 1.84, 1.76 and 1.58 fold higher
than the normal control group in Sildenafil, Tribulus
and Ashwagandha groups respectively (P < 0.0001).
Mucuna pruriens administration did not show signifi-
cance on serum testosterone levels when compared to
standard control group of rats (P > 0.05). All of the ex-
tract treatments to the groups lowered the serum and
testis tissue MDA levels significantly, in comparison to
sildenafil group of rats (P < 0.0001). The most prom-
inent ameliorating decrease was in Tribulus group
with a 32 % in serum and 14 % in testis MDA levels
(P < 0.0001).
Figure 1(a–d), shows the western blot bands of the
Control, Sildenafil, Mucuna, Tribulus and Ashwagandha
plant extract groups on the expression levels of NF-κB
and HO-1/Nrf2 in reproductive tissues which included
epididymis, prostate, testes and vas deferens. In the epi-
didymis tissue (Fig. 2a–c), higher levels of HO-1/Nrf2
were found in Tribulus, Mucuna and Ashwagandha
groups compared to the other groups, in contrast, NF-
κB levels were significantly lower in Tribulus, Mucuna
and Ashwagandha administered groups (P < 0.0001). In
the prostate tissue, HO-1/Nrf2 levels of Tribulus,
Table 3 The effects of extracts on sperm characteristics and abnormal sperm rate (%) in rats
Item Groups –P–
Control Sildenafil Mucuna pruriens Tribulus terrestris Ashwagandha
Total Motility,% 75.00 ± 5.49bc 80.00 ± 4.16b 80.00 ± 4.16b 84.29 ± 5.34a 78.00 ± 5.37b <0.05
Count * 110.33 ± 37.78b 146.29 ± 21.55a 148.57 ± 31.45a 161.42 ± 36.11a 154.80 ± 10.55a <0.05
Abnormal sperm rate, %
Head 5.00 ± 3.85 3.71 ± 2.56 4.43 ± 2.76 3.00 ± 1.53 5.40 ± 2.88 >0.05
Tail 5.17 ± 2.14 4.86 ± 1.35 5.00 ± 2.45 3.86 ± 1.68 7.40 ± 3.21 >0.05
Total 10.17 ± 4.71 8.57 ± 2.37 9.43 ± 3.82 6.86 ± 2.11 12.80 ± 5.31 >0.05
Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with
Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the
same row (a–c) indicate group mean differences (p < 0.05). *Million/right cauda epididymis
Table 2 The effects of extracts on sexual behaviors in rats
Item Groups –P–
Control Sildenafil Mucuna pruriens Tribulus terrestris Ashwagandha
Mounting Latency, sec 9.48 ± 1.20a 2.10 ± 0.34d 5.27 ± 0.62b 2.86 ± 0.62cd 3.15 ± 0.60c 0.0001
Mounting Frequency* 65.65 ± 8.19d 214.27 ± 17.76a 118.99 ± 7.51c 170.86 ± 10.42b 167.72 ± 14.91b 0.0001
Intromission Latency, sec 9.40 ± 1.07a 0.98 ± 0.22d 4.87 ± 0.50b 2.13 ± 0.15c 2.73 ± 0.40c 0.0001
Intromission Frequency* 59.51 ± 4.70d 203.90 ± 15.78a 132.03 ± 11.32c 173.71 ± 14.02b 169.70 ± 18.41b 0.0001
Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with
Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the
same row (a–c) indicate group mean differences (p < 0.05). * The number of intromissions in an ejaculatory series
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Mucuna, and Ashwagandha extract treated groups sig-
nificantly increased compared to the negative and posi-
tive controls while NF-κB levels decreased considerably
in the same groups compared to the both controls
(Fig. 3a–c), (P < 0.0001). Tribulus and Mucuna extract
treated groups showed higher HO-1 levels in testis tissue
than the other groups and also Tribulus, Mucuna and
Ashwagandha groups Nrf2 levels were significantly
higher than Sildenafil and Standard control (Fig. 4a,c),
(P < 0.0001). Furthermore, the least NF-κB expression
level was found in Tribulus group in the testes and also
Mucuna and Ashwagandha groups suggested a signifi-
cant decrease in comparison to positive control Silden-
afil group (Fig. 4b) (P < 0.0001). In vas deferens tissue
HO-1 expression, Tribulus extract treated rats showed
the highest levels among the groups (Fig. 5a) (P <
0.0001), while significantly higher Nrf2 levels, were
again found in Tribulus and moreover Ashwagandha
groups (Fig. 5c) (P < 0.0001). All herbal extract treated
groups showed significantly lower NF-κB levels when
compared to both positive and negative controls
(Fig. 5b) (P < 0.0001).
Table 5 The effects of extracts on serum biochemical parameters in rats
Item Groups –P–
Control Sildenafil Mucuna pruriens Tribulus terrestris Ashwagandha
AST, U/L 97.50 ± 8.92 118.86 ± 33.73 99.29 ± 15.85 104.29 ± 21.86 108.51 ± 23.25 >0.05
ALT, U/L 46.67 ± 6.50 59.86 ± 10.48 48.71 ± 6.78 47.71 ± 10.24 50.00 ± 10.05 >0.05
ALP, U/L 204.00 ± 43.32a 202.14 ± 31.02a 161.86 ± 29.29b 215.86 ± 25.58a 202.00 ± 22.03a 0.0349
CK, U/L 531.00 ± 224.85 399.29 ± 292.28 405.86 ± 189.07 226.86 ± 102.12 331.40 ± 44.57 >0.05
Urea, mg/dl 33.00 ± 2.61 36.43 ± 2.07 36.14 ± 5.08 36.00 ± .3.74 36.80 ± 6.18 >0.05
Creatine, mg/dl 0.30 ± 0.03 0.28 ± 0.03 0.28 ± 0.04 0.29 ± 0.02 0.30 ± 0.03 >0.05
AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, CK creatine kinase control, no treatment; Sildenafil, rats treated with
Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with Tribulus terrestris (300 mg/kg bw); Ashwagandha;
rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the same row (a–c) indicate group mean differences (p < 0.05)
Table 4 The effects of extracts on blood parameters in rats
Item Groups –P–
Control Sildenafil Mucuna pruriens Tribulus terrestris Ashwagandha
L WBC 8.59 ± 0.31 8.73 ± 0.34 8.66 ± 0.45 8.98 ± 0.68 8.59 ± 0.22 >0.05
LYM, % 62.03 ± 7.18 62.53 ± 5.90 60.98 ± 12.69 61.19 ± 9.99 64.58 ± 4.47 >0.05
MID, % 14.07 ± 4.37 12.31 ± 3.85 12.20 ± 2.63 16.30 ± 6.67 11.82 ± 4.39 >0.05
GRAN, % 23.90 ± 5.26 25.16 ± 6.01 26.81 ± 13.67 22.51 ± 3.99 23.60 ± 3.10 >0.05
MID, # 10*3/μl 6.62 ± 0.53 6.60 ± 0.52 6.53 ± 0.39 7.11 ± 0.94 6.35 ± 0.65 >0.05
GRAN, # 10*3/μl 7.13 ± 0.42 7.32 ± 0.39 7.26 ± 0.79 7.46 ± 0.87 7.16 ± 0.23 >0.05
RBC, 10*6/μl 15.96 ± 0.05 15.96 ± 0.5 16.00 ± 0.06 15.96 ± 0.07 15.99 ± 0.04 >0.05
HGB, g/dL 16.27 ± 0.96 16.14 ± 0.65 16.57 ± 0.81 16.14 ± 1.06 16.60 ± 0.67 >0.05
HCT, % 81.27 ± 5.63 79.93 ± 3.51 81.63 ± 3.62 80.64 ± 5.79 81.16 ± 2.78 >0.05
MCV, fL 94.75 ± 2.56 94.13 ± 5.61 91.94 ± 4.42 94.69 ± 2.81 91.90 ± 1.76 >0.05
MCH, pg 18.90 ± 0.37 18.94 ± 0.88 18.29 ± 0.56 18.89 ± 0.38 18.72 ± 0.50 >0.05
MCHC, d/dL 19.97 ± 0.60 20.14 ± 0.40 20.24 ± 0.51 19.56 ± 1.38 20.42 ± 0.33 >0.05
RDW-CV, % 17.32 ± 0.58 16.47 ± 1.36 17.24 ± 1.19 17.90 ± 1.09 17.76 ± 0.83 >0.05
PLT, 10*3/μl 13.79 ± 0.11 13.60 ± 0.17 13.82 ± 0.20 13.76 ± 0.19 13.85 ± 0.20 >0.05
MPV, fL 11.62 ± 0.35 11.36 ± 0.46 11.86 ± 0.16 11.44 ± 0.40 11.68 ± 0.22 >0.05
PDW, % 17.53 ± 1.31 16.99 ± 1.09 16.74 ± 1.36 16.83 ± 0.94 16.20 ± 0.91 >0.05
PCT, % 1.14 ± 0.13 0.92 ± 0.15 1.22 ± 0.28 1.09 ± 0.24 1.22 ± 0.21 >0.05
LWBC leukocyte white blood cells, LYM lymphocyte, MID minimum inhibitory dilution, GRAN granulocyte, RBC red blood cell, HGB hemoglobin, HCT hematocrit,
MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, RDW-CV red cell distribution width-
coefficient variation, PLT platelet, MPV mean platelet volume, PDW platelet distribution width, PCT platelet crit; Control, no treatment; Sildenafil, rats treated with
Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with Tribulus terrestris (300 mg/kg bw); Ashwagandha;
rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the same row (a–c) indicate group mean
differences (p < 0.05)
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No significant change was observed neither in testes
histopathology nor the sperm morphologies between the
groups as shown in (Fig. 6a–e).
Discussion
Male infertility, erectile dysfunction, and reproductive
system problems are common public health disorders
besides a stressed out way of life has been increasing the
sexual dysfunction suffering subjects around the world
[2, 35]. A better understanding of erectile and sexual
functions at molecular levels in the male reproductive
system shall be a great achievement for the aim of pre-
cise aphrodisiac substance choice [35]. In this study, we
tried to figure out the sexual enhancing capacity, blood
and serum biochemical parameters and hormones, anti-
oxidant capacity by assessing the serum and testis MDA
and Nrf2 pathway of reproductive organ parts of the
male rats by feeding the animals with Tribulus terrestris,
Fig. 1 Epididymis tissue NF-κB, Nrf-2 and HO-1 levels (a); prostate tissue NF-κB, Nrf-2 and HO-1 levels (b); testes tissue NF-κB, Nrf-2 and HO-1
levels (c); vas deferens tissue NF-κB, Nrf-2 and HO-1 levels (d) western blot bands. Data are expressed as a ratio of normal control value (set to
100 %). Blots were repeated at least 4 times (n = 4) and a representative blot is shown. Actin was included to ensure equal protein loading. The
bars represent the standard error of the mean. Data points with different superscripts are significantly different at the level of P < 0.05 by Fisher’s
multiple comparison test
Table 6 The effects of extracts on serum hormones and MDA levels in rats
Item Groups –P–
Control Sildenafil Mucuna pruriens Tribulus terrestris Ashwagandha
FSH, mIU/ml 0.33 ± 0.22 0.40 ± 0.37 0.31 ± 0.25 0.34 ± 0.39 0.31 ± 0.24 >0.05
LH, mIU/ml 0.22 ± 0.29 0.30 ± 0.23 0.25 ± 0.17 0.24 ± 0.19 0.27 ± 0.19 >0.05
Testosterone, ng/ml 2.27 ± 0.17c 4.14 ± 0.71a 2.57 ± 0.44c 3.99 ± 0.16ab 3.58 ± 0.18b 0.0001
Serum MDA, μmol/L 0.54 ± 0.05a 0.56 ± 0.06a 0.49 ± 0.04b 0.38 ± 0.02c 0.44 ± 0.02b 0.0001
Testis MDA, nmol/g 1.64 ± 0.09ab 1.68 ± 0.09a 1.55 ± 0.06cb 1.45 ± 0.09d 1.51 ± 0.07cd 0.0001
FSH follicle-stimulating hormone, LH luteinizing hormone, MDA malonaldeyhde; Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna,
rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha
(300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the same row (a–c) indicate group mean differences (p < 0.05)
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Mucuna pruriens and Ashwagandha extracts and com-
paring them with standard control group and sildenafil-
treated group as a positive control.
Mucuna pruriens is a traditional Ayurvedic Indian me-
dicinal plant and has been used in Indian medicine for a
long time. The total alkaloids from Mucuna seeds were
reported to increase sperm production and weight of
some reproductive organ parts in the albino rats [36]. In
our study, we also found out an increase of the sperm
production by the effect of the Mucuna and the other
extracts but there was no significant change observed in
any reproductive tissue weights according to our results.
In many studies, Mucuna pruriens seed powder were
observed to significantly and sustainably improve sexual
behaviors such as; increased mounting frequency and
intromission frequency and decreased mounting latency
and intromission latency as parallel to our results
[37–39]. However, Mucuna pruriens hydrolysates were
shown to be hypocholesterolemic and hypolipidemic
effective and rich in protein content [40]. Diminishing
the ROS level, MMP renewal, and apoptosis regula-
tion through Mucuna pruriens improved the sperm-
atogenesis mainly via its major component L-DOPA
was shown in previous studies [41, 42], similarly as
our study showed decreasing MDA levels, NF-κB protein
expression, and increasing HO-1/NrF-2 levels correspond-
ingly. Mucuna administration increased testosterone and
LH levels and decreased lipid peroxidation and FSH in in-
fertile men also stimulated the antioxidant enzymes and
hormones such as catalase, SOD and GSH via reactivating
the antioxidant defense system and recovered sperm
count and motility [43–45]. In parallel to previous results,
Fig. 3 HO-1 (a), NF-κB (b) and Nrf-2 (c) Protein levels of prostate tissue in male rats (P < 0.0001). Data are expressed as a ratio of normal control
value (set to 100 %). Blots were repeated at least 4 times (n = 4) and a representative blot is shown. Actin was included to ensure equal protein
loading. The bars represent the standard error of the mean. Data points with different superscripts are significantly
Fig. 2 HO-1 (a), NF-κB (b) and Nrf-2 (c) Protein levels of epididymis tissue in male rats (P < 0.0001). Data are expressed as a ratio of normal control
value (set to 100 %). Blots were repeated at least 4 times (n = 4) and a representative blot is shown. Actin was included to ensure equal protein
loading. The bars represent the standard error of the mean. Data points with different superscripts are significantly different at the level of P < 0.05 by
Fisher’s multiple comparison test
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Mucuna pruriens treatment improved testosterone levels
and significantly recovered sperm count and motility also
lowered lipid peroxidation significantly but did not alter
the FSH and LH levels in our study.
Tribulus terrestris is regarded to be an aphrodisiac
herb and has been used in traditional Far East medicine
for ages because of its reputation to improve sexual
functions along with its beneficial effects on various dis-
eases [21, 22, 35, 46]. It was shown that Tribulus terres-
tris administration improved LH also sperm production
and testosterone levels in rams [47] as we consistently
showed its enhancing effect on sperm counts and testos-
terone levels except LH levels were determined indiffer-
ent than the control. According to our study, Tribulus
group showed significant improvements in sexual behav-
iors, including; increased mounting and intromission
frequencies and decreased mounting and intromission la-
tencies similar to previously reported studies [7, 21, 48].
Tribulus terrestris were shown to increase the nitric oxide
release and this is considered for its aphrodisiac capacity
character [48, 49]. Our results suggested major increases
in Nrf-2 and HO-1 levels and decreases in NF-κB and
MDA levels of the various reproductive tissue parts and
serum when administered with Tribulus terrestris similarly
to a study which the extract was restored antioxidant en-
zyme activity and their expression profile in kidney tissue
[50] and another study that extract blocked proliferation
and induced apoptosis in cancer cells through the inhib-
ition of NF-κB signaling [51].
Ashwagandha (Withania somnifera) has been known
as Indian Ginseng and regarded as adaptogen, tonic with
its aphrodisiac properties [35]. Even though an old study
Fig. 5 HO-1 (a), NF-κB (b) and Nrf-2 (c) Protein levels of vas deferens tissue in male rats (P < 0.0001). Data are expressed as a ratio of normal
control value (set to 100 %). Blots were repeated at least 4 times (n = 4) and a representative blot is shown. Actin was included to ensure equal
protein loading. The bars represent the standard error of the mean. Data points with different superscripts are significantly different at the level of
P < 0.05 by Fisher’s multiple comparison test
Fig. 4 HO-1 (a), NF-κB (b) and Nrf-2 (c) levels of testes tissue in male rats (P < 0.0001). Data are expressed as a ratio of normal control value (set
to 100 %). Blots were repeated at least 4 times (n = 4) and a representative blot is shown. Actin was included to ensure equal protein loading.
The bars represent the standard error of the mean. Data points with different superscripts are significantly different at the level of P < 0.05 by Fish-
er’s multiple comparison test
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reported that it was shown as antifertility effective and
mating behavior reducer in mice [52], recent studies re-
ported its capability of combating stress-induced infertil-
ity and its protective effect to some reproductive
endocrine dysfunctions in male rats were shown [53,
54]. Our study has been suggested Ashwagandha be ef-
fective as a sexual enhancer not as satisfactory as Tribu-
lus terrestris but reasonably adequate.
Conclusions
The present study provides evidence that the extracts of
Tribulus, Ashwagandha and Mucuna are potent en-
hancers of sexual function and behavior by the increas-
ing testosterone levels and regulation of NF-κB and
Nrf2/HO–1 pathways in male rats. The results of the
present study have also indicated that Tribulus extract
was comparatively more potent than the corresponding
Ashwagandha and Mucuna extracts for the sexual func-
tions. Moreover, further studies should be carried out to
check the molecular markers related to the sexual func-
tion in male rats.
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